Navigation Links
Potential cure for captive amphibians with chytrid fungus
Date:5/12/2014

Researchers at Vanderbilt University have identified an alternative to a sometimes toxic therapy that protects frogs in zoos from a deadly fungal infection that has been destroying the amphibian populations worldwide. Their research is published ahead of print in Applied and Environmental Microbiology.

The fungal disease, chytridiomycosis, has been decimating frogs all over the world. At present, nothing can help amphibians in the wild, but zoos currently rely on the often-toxic itraconazole to eradicate the disease from infected amphibians they wish to acquire.

To preserve the most at risk amphibians, zoos have been acquiring "founding populations" of species threatened by chytridiomycosis, which is caused by the fungus, Batrachochytrium dendrobatidis.

"Some species, such as the Panamanian Golden Frog, are nearly extinct in nature, and doing well only in zoos," says Louise Rollins-Smith, a researcher on the study. "Facilities which house multiple amphibian species need safe treatments to protect their valuable colonies."

Brian Gratwicke, a conservation biologist with the National Zoo, describes the difficulties zoos face in treating the creatures. The animals must go through 10 days of immersion in an itraconazole solution.

"Itraconazole is a fairly expensive drug, and depending on the species we treat we can see a very high mortality rate," says Gratwicke. "An alternative treatment would be very helpful."

In the study, Rollins-Smith and colleagues, of Vanderbilt University, Nashville, TN, tested two potential alternatives, chloramphenicol, and amphotericin B. Although both drugs reduced B. dendrobatidis infection, neither could eradicate it. But amphotericin B had a critical advantage over chloramphenicol.

The investigators found that chloramphenicol can cause major changes in the community of microbes inhabiting amphibian skin, while amphotericin B does not, says Rollins-Smit
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mouse study points to potentially powerful tool for treating damaged hearts
2. Study yields potential drug targets for preeclampsia patients
3. RNA shows potential as boiling-resistant anionic polymer material for nanoarchitectures
4. UCI study finds modified stem cells offer potential pathway to treat Alzheimers disease
5. Scientists reveal potential link between brain development and breast cancer gene
6. Dartmouth researchers identify potential therapeutic target for deadly brain cancer
7. Scientists find potential drug targets in deadly pediatric brain tumors
8. Unzipping poplars biofuel potential
9. Crib mattresses emit potentially harmful chemicals, Cockrell School engineers find
10. Beer marinade could reduce levels of potentially harmful substances in grilled meats
11. New international partnership aims to unlock wheats potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
(Date:2/5/2015)... --NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the growing mobile commerce market, announces the launch ... part of its 2015 marketing and branding initiatives for ... consumer website for Wocketwallet.com earlier this month. ... "Our new corporate website naturally showcases our premiere consumer ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... Australian parents need to be educated about managing fever ... often unnecessarily, according to a Queensland University of Technology ... conducted the first study into how Australian parents, manage ... results were published in the latest Journal of Paediatrics ...
... 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) a ... that it has acquired a patent that covers ... locks. The company believes that this patent ... years, consumers have been using portable locks, such ...
... of a science fiction thriller, researchers at UC Davis have ... of jaws located in the moray,s throat reaches forward into ... the esophagus for swallowing. "This is really an amazing ... Mehta, a postdoctoral researcher in the Section of Evolution and ...
Cached Biology News:Fever causing headaches for Aussie parents 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2'Alien' jaws help moray eels feed 2
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its valued ... received the 2015 Tomorrow’s Top Producer Horizon Award. The ... 35, who has demonstrated excellence in the business of ... Tomorrow's Top Producer Horizon Award. Every year I look ... and learning from their experiences. It is truly humbling ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... September 3 Debiopharm Group, SA,(Debiopharm), a Swiss-based ... the development of prescription drugs that target unmet ... to Dr Lluis,Quintana-Murci from the Institut Pasteur in ... field of evolutionary genetics of,infection. Funded by Debiopharm, ...
... Ontario, Sept. 3 Helix BioPharma Corp. (TSX, FSE: "HBP" ... chief operating officer, will present at the Rodman and Renshaw ... Sept. 9, at the New York Palace Hotel in New ... Company,s leading product development programs L-DOS47 and Topical Interferon Alpha-2b. ...
... Sept. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: ... China, announced today that,the State Food and Drug Administration ... vaccine, and has issued Sinovac a,production license for this ... which showed that PANFLU.1, Sinovac,s H1N1,vaccine, has a good ...
Cached Biology Technology:The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana-Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana-Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 3Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 2Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 3Sinovac Obtains Production License for H1N1 Vaccine 2Sinovac Obtains Production License for H1N1 Vaccine 3
Canine Chondrocytes (CnC) (500,000 cells)...
... Hex, Tet Cy3, Cy5, Texas Red, ... Hole Quenchers Molecular Beacons* ... 3 Dabcyl Dabcyl*Licensed from the ... labelled probes are purified either by HPLC ...
... Varioskan is a high performance ... dispenser and incubator. With the advanced ... and reliability for drug discovery assay ... for fluorescence intensity, time-resolved fluorescence and ...
Roll of Mesh 5m x 25cm...
Biology Products: